These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 28903883)

  • 21. Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large Cohort.
    Vengalil S; Preethish-Kumar V; Polavarapu K; Mahadevappa M; Sekar D; Purushottam M; Thomas PT; Nashi S; Nalini A
    J Clin Neurol; 2017 Jan; 13(1):91-97. PubMed ID: 28079318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutation analysis and prenatal diagnosis for 50 pedigrees affected with Duchenne/Becker muscular dystrophy].
    Li H; Xu C; Mao Y; Lu J; Xiang Y; Xu X; Tang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):169-174. PubMed ID: 29652985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive genetic analysis of 961 unrelated Duchenne Muscular Dystrophy patients: Focus on diagnosis, prevention and therapeutic possibilities.
    Kumar SH; Athimoolam K; Suraj M; Das Christu Das MS; Muralidharan A; Jeyam D; Ashokan J; Karthikeyan P; Krishna R; Khanna-Gupta A; Bremadesam Raman L
    PLoS One; 2020; 15(6):e0232654. PubMed ID: 32559196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A predictive analysis of the association between clinical phenotypes and genotypes in children with Becker muscular dystrophy/Duchenne muscular dystrophy].
    Niu HH; Tao DY; Cheng SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):602-607. PubMed ID: 32571459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of deletions and duplications in the Duchenne muscular dystrophy gene and female carrier status in western India using combined methods of multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification.
    Dastur RS; Kachwala MY; Khadilkar SV; Hegde MR; Gaitonde PS
    Neurol India; 2011; 59(6):803-9. PubMed ID: 22234189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLPA based detection of mutations in the dystrophin gene of 180 Polish families with Duchenne/Becker muscular dystrophy.
    Zimowski JG; Massalska D; Holding M; Jadczak S; Fidziańska E; Lusakowska A; Kostera-Pruszczyk A; Kamińska A; Zaremba J
    Neurol Neurochir Pol; 2014; 48(6):416-22. PubMed ID: 25482253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MLPA analysis/complete sequencing of the DMD gene in a group of Bulgarian Duchenne/Becker muscular dystrophy patients.
    Todorova A; Todorov T; Georgieva B; Lukova M; Guergueltcheva V; Kremensky I; Mitev V
    Neuromuscul Disord; 2008 Aug; 18(8):667-70. PubMed ID: 18653336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India.
    Deepha S; Vengalil S; Preethish-Kumar V; Polavarapu K; Nalini A; Gayathri N; Purushottam M
    BMC Med Genet; 2017 Jun; 18(1):67. PubMed ID: 28610567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differing disease phenotypes of Duchenne muscular dystrophy and Moyamoya disease in female siblings of a Korean family.
    Park J; Jang W; Han JY
    Mol Genet Genomic Med; 2019 Sep; 7(9):e862. PubMed ID: 31347299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation spectrum analysis of Duchenne/Becker muscular dystrophy in 68 families in Kuwait: The era of personalized medicine.
    Mohammed F; Elshafey A; Al-Balool H; Alaboud H; Al Ben Ali M; Baqer A; Bastaki L
    PLoS One; 2018; 13(5):e0197205. PubMed ID: 29847600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of ambiguous MLPA results by targeted next-generation sequencing discloses a nonsense mutation in the DMD gene.
    Niba ET; Tran VK; Tuan-Pham le A; Vu DC; Nguyen NK; Ta VT; Tran TH; Lee T; Takeshima Y; Matsuo M
    Clin Chim Acta; 2014 Sep; 436():155-9. PubMed ID: 24892813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy.
    Zhang S; Qin D; Wu L; Li M; Song L; Wei C; Lu C; Zhang X; Hong S; Ma M; Wu S;
    Orphanet J Rare Dis; 2021 Apr; 16(1):188. PubMed ID: 33910603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic diagnosis of Duchenne and Becker muscular dystrophy using multiplex ligation-dependent probe amplification in Rwandan patients.
    Uwineza A; Hitayezu J; Murorunkwere S; Ndinkabandi J; Kalala Malu CK; Caberg JH; Dideberg V; Bours V; Mutesa L
    J Trop Pediatr; 2014 Apr; 60(2):112-7. PubMed ID: 24213305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DMD-related muscular dystrophy in Cameroon: Clinical and genetic profiles.
    Wonkam-Tingang E; Nguefack S; Esterhuizen AI; Chelo D; Wonkam A
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1362. PubMed ID: 32543101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.
    Koeks Z; Bladen CL; Salgado D; van Zwet E; Pogoryelova O; McMacken G; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Bellgard MI; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lähdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Herczegfalvi A; Viswanathan V; Bayat F; Buccella F; Ferlini A; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Klein A; Díaz-Manera J; Gallardo E; Karaduman AA; Oznur T; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Kirschner J; Flanigan KM; Straub V; Bushby K; Béroud C; Verschuuren JJ; Lochmüller H
    J Neuromuscul Dis; 2017; 4(4):293-306. PubMed ID: 29125504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategy for comprehensive molecular testing for Duchenne and Becker muscular dystrophies.
    Stockley TL; Akber S; Bulgin N; Ray PN
    Genet Test; 2006; 10(4):229-43. PubMed ID: 17253928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid method for targeted prenatal diagnosis of Duchenne muscular dystrophy in Vietnam.
    Ta MH; Tran TH; Do NH; Pham le AT; Bui TH; Ta VT; Tran VK
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):534-9. PubMed ID: 24411039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.
    Preethish-Kumar V; Shah A; Kumar M; Ingalhalikar M; Polavarapu K; Afsar M; Rajeswaran J; Vengalil S; Nashi S; Thomas PT; Sadasivan A; Warrier M; Nalini A; Saini J
    AJNR Am J Neuroradiol; 2020 Jul; 41(7):1271-1278. PubMed ID: 32616576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.
    Bello L; Morgenroth LP; Gordish-Dressman H; Hoffman EP; McDonald CM; Cirak S;
    Neurology; 2016 Jul; 87(4):401-9. PubMed ID: 27343068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.